Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson vaccine could be submitted for emergency use by late January and is the only vaccine among leading candidates given as a single dose.

There was new information released from the North Carolina Department of Health and Human services that people who have not had the vaccine are are 15.4 times more likely, which equates to 1,504 percent more likely to die if they were to contract covid 19.

There were 912 adults in the ICU because of COVID and 574 patients on ventilators which are both record for the state of North Carolina. During the week ending Aug. 21, unvaccinated people were also 4.4 times, or 440 percent, more likely to catch COVID-19 than vaccinated people.

North Carolina has been experiencing the fastest acceleration in cases and hospitalizations since the pandemic started. The COVID-19 vaccines authorized and approved in the United States continue to be effective in reducing risk of severe disease, hospitalization and death, even against the widely circulating Delta variant, according to officials.

While vaccines are the best protection against serious illness, hospitalization and death, monoclonal antibody therapy can reduce the severity of COVID-19 symptoms and decrease the likelihood of hospitalization, especially in high-risk patients. If you test positive for COVID-19, monoclonal antibody therapy must be administered within 10 days of your first COVID-19 symptoms, so it is crucial to get tested early.